JohnClaiborneMD

Hematology/Oncology

Physician

Dr. Claiborne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
201 N Broadway
Suite 600
Baltimore, MD 21287
Phone+1 410-955-8893

Fax+1 410-367-2194

PubMed

18 citations
Managing post allograft relapse of myeloid neoplasms: azacitidine and donor lymphocyte infusions as salvage therapy.
John Preston Claiborne, Dipankar Bandyopathyay, Catherine H. Roberts, Kelly G. Hawks, May Aziz
Leukemia & Lymphoma. 2019-05-03
Recent trends in diabetes-related consumer health information technology research
John Preston Claiborne, Claire A. Wellbeloved-Stone, Rupa S. Valdez
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2019-07-01

Journal Articles

Use of immune checkpoint inhibition and conventional chemotherapy for multiple, concurrent malignancies post-lung transplantation: A case report
Claiborne JP, Mirkheshti N, Koka R, Timofte IL, Cullen KJ, Current Problems in Cancer: Case Reports, 6/2022

Abstracts/Posters

Recent trends in diabetes-related consumer health information technology research
Claiborne JP, Wellbeloved-Stone C, Valdez RS, Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Berlin, Germany, 7/26/2019
Chronic graft-versus-host disease and disease status at relapse as predictors of clinical outcomes in patients receiving azacitidine & donor lymphocyte infusions as sa...
Claiborne J, Roberts C, Hawks K, Bandyopadhyay D, Simmons G, Wiedl C, Chung H, Clark W, McCarty J, Toor A, ASBMT BMT Tandem Meetings, Salt Lake City, UT, 2/2018